Potential of x-ray tomosynthesis in diagnosis of breast diseases under the assisted reproductive technologies programme

2017 ◽  
Vol 16 (4) ◽  
pp. 13-16
Author(s):  
L.D. Belotserkovtseva ◽  
◽  
N.V. Klimova ◽  
Z.O. Sarsebaeva ◽  
◽  
...  
Keyword(s):  
Assisted Reproductive Technologies ◽  
Reproductive Technologies ◽  
Breast Diseases ◽  
X Ray

Diagnosis of breast diseases under the assisted reproductive technologies programme

2020 ◽  
Vol 19 (4) ◽  
pp. 70-74
Author(s):  
L.D. Belotserkovtseva ◽  
◽  
N.V. Klimova ◽  
L.V. Kovalenko ◽  
V.V. Danilogorskaya ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Assisted Reproductive Technologies ◽  
Reproductive Technologies ◽  
The State ◽  
Diagnostic Methods ◽  
Breast Diseases ◽  
Old Patients ◽  
Core Needle ◽  
X Ray ◽  
Radiation Imaging

Objective. To study the state of the breasts in women who undergo assisted reproductive technologies treatment, using modern methods of radiation imaging. Patients and methods. Pre- and prospective examination and analysis of the data of radiation imaging of the breasts of 220 women, having tubal factor infertility in combination with benign mammary dysplasia, who have successful or unsuccessful experience of participation in assisted reproductive technology programmes. The average age of patients was 42.5 years. Assessment points were: breast tissue density according to the findings of ultrasound, mammography and tomosynthesis, presence of clustered microcalcifications, presence of benign dysplastic processes and fibroadenomas of the breasts. Results. In the group of 35–39-year old patients, the most common pathological processes were fibrocystic mastopathy and fibroadenomas. The main diagnostic methods were ultrasound visualization and US-controlled core-needle vacuum-assisted biopsy. In the group of 40–44-year old women, the predominant pathological process was microcalcification clusters alongside high mammographic density. The main diagnostic methods were digital x-ray tomosynthesis and X-ray-guided core-needle vacuum-assisted biopsy. In the group of 45–49-year old women, cases of breast cancer were diagnosed. 12 women in this group had breast implants. Conclusion. Hormonal medication used in assisted reproductive technologies under the protocols of in-vitro fertilization and intracytoplasmatic sperm injection influence the state of the breasts, increasing a risk of developing diffuse benign mammary dysplasias and, quite possible, a risk of developing breast cancer later in life. Key words: breast diseases, assisted reproductive technologies, tomosynthesis, mammotome, clustered microcalcifications

Re-imagining Reproduction: Unsettling Metaphors in the History of Imperial Science and Commercial Surrogacy in India

Somatechnics ◽  
2015 ◽  
Vol 5 (1) ◽  
pp. 88-103 ◽  
Author(s):  
Kalindi Vora
Keyword(s):  
Assisted Reproductive Technologies ◽  
Reproductive Technologies ◽  
The Body ◽  
Body Parts ◽  
Colonial History ◽  
Women's Bodies ◽  
Commercial Surrogacy ◽  
Art Practices ◽  
History Of ◽  
Travel Industry

This paper provides an analysis of how cultural notions of the body and kinship conveyed through Western medical technologies and practices in Assisted Reproductive Technologies (ART) bring together India's colonial history and its economic development through outsourcing, globalisation and instrumentalised notions of the reproductive body in transnational commercial surrogacy. Essential to this industry is the concept of the disembodied uterus that has arisen in scientific and medical practice, which allows for the logic of the ‘gestational carrier’ as a functional role in ART practices, and therefore in transnational medical fertility travel to India. Highlighting the instrumentalisation of the uterus as an alienable component of a body and subject – and therefore of women's bodies in surrogacy – helps elucidate some of the material and political stakes that accompany the growth of the fertility travel industry in India, where histories of privilege and difference converge. I conclude that the metaphors we use to structure our understanding of bodies and body parts impact how we imagine appropriate roles for people and their bodies in ways that are still deeply entangled with imperial histories of science, and these histories shape the contemporary disparities found in access to medical and legal protections among participants in transnational surrogacy arrangements.

Features hormonal hemostasis in patients with benign hyper-plastic processes of breasts

2016 ◽  
pp. 72-74 ◽  
Author(s):  
M. Makarenko ◽  
◽  
D. Govsieiev ◽  
O. Gromova ◽  
L. Martynova ◽  
...  
Keyword(s):  
Luteal Phase ◽  
Reproductive Organs ◽  
Breast Diseases ◽  
Hormonal Changes ◽  
Morphological Investigation ◽  
Fibrocystic Disease ◽  
X Ray ◽  
Pelvic Organs ◽  
Hormone Research ◽  
Gynecological Diseases

The objective: to study the incidence of gynecological diseases, clinical and hormonal parameters of the menstrual cycle in patients with benign hyper-plastic processes of breasts. Patients and methods. 65 women with various forms of mastitis were investigated. The following investigations were conducted: mammologistic and gynecological investigation, mommologistic X-ray investigation, ultrasound of breasts and of the pelvic organs, endometrial aspiration biopsy that was followed by cytology; when it was necessary the diagnostic laparoscopy, colposcopy, hysteroscope with curettage and morphological investigation of the endometrium, hormone research and rectal temperature measurements were conducted. Results. The frequency of the benign breast diseases was set: fibrocystic disease of breast – 32 women (49.2±6.20%), fibrous of breast – 16 women (24.6±5.34%), nodular of breasts – 8 women (12.3±4.07%), fibroadenoma – 6 women (9.2±3.59%), nodular disease of breasts on the background of fibroid changes – 3 women (4.6±2.60%). All in all, 96.9±2.14% of the patients had any gynecological diseases. Thus, the average age of the ‘debut’ of mastitis was 31.4±1.09 years; the hyper-plastic processes in the uterus was 35.2±1.17 years. Anovulation was detected in 17 (47.2±8.3%) patients, the lack of the luteal phase (NLF) was detected in 11 (30.6±7.6) patients. Conclusions. Identified hormonal changes are typical for patients with the hyper-plastic processes of the reproductive organs with different localization (breasts, uterus, ovaries). Due to the commonality of the hormone changes in most cases mastitis is combined with the various gynecological diseases (96.9±2.14%). Key words: gynecological pathology, hormonal changes, breast, factors of risk.

The role of the growth hormone in assisted reproductive technologies cycles

GYNECOLOGY ◽  
2019 ◽  
Vol 21 (4) ◽  
pp. 6-8
Author(s):  
Andrey Y Romanov ◽  
Anastasiya G Syrkasheva ◽  
Nataliya V Dolgushina ◽  
Elena A Kalinina
Keyword(s):  
Growth Hormone ◽  
Live Birth ◽  
Ovarian Stimulation ◽  
Assisted Reproductive Technologies ◽  
Polycystic Ovary ◽  
Live Birth Rate ◽  
Reproductive Technologies ◽  
Blood Levels ◽  
Main Research ◽  
Poor Ovarian Responders

The paper analyzes the literature data on the use of the growth hormone (GH) in ovarian stimulation in assisted reproductive technologies (ART). Routine use of GH in ovarian stimulation in patients with a normal GH level does not increase pregnancy and childbirth rates in ART. Also, no benefits of using GH have been identified for patients with polycystic ovary syndrome, despite the increase in insulin and IGF-1 blood levels. The main research focus is to study the use of GH in patients with poor ovarian response. According to the meta-analysis conducted by X.-L. Li et al. (2017), GH in ovarian stimulation of poor ovarian responders increases the number of received oocytes, mature oocytes number, reduces the embryo transfer cancellation rate and does not affect the fertilization rate. The pregnancy and live birth rates are significantly higher in the group of GH use - by 1.65 (95% CI 1.23-2.22) and 1.73 (95% CI 1.25-2.40) times, respectively. Thus, it is advisable to use GH in ovarian stimulation in poor ovarian responders, since it allows to increases live birth rate in ART. However, further studies should determine the optimal GH dose and assesse it`s safety in ART programs.

The efficacy of assisted reproductive technologies in patients with uterine fibroids (review)

GYNECOLOGY ◽  
2015 ◽  
pp. 60-64
Author(s):  
N.M. Podzolkova ◽  
◽  
Yu.A. Koloda ◽  
V.V. Korennaya ◽  
K.N. Kayibkhanova ◽  
...  
Keyword(s):  
Assisted Reproductive Technologies ◽  
Uterine Fibroids ◽  
Reproductive Technologies

Thickness of endometrium: predictor of the effectiveness of IVF/ICSI programs (literature review)

GYNECOLOGY ◽  
2018 ◽  
Vol 20 (1) ◽  
pp. 113-116
Author(s):  
L A Bagdasaryan ◽  
I E Korneyeva
Keyword(s):  
Assisted Reproductive Technologies ◽  
Endometrial Thickness ◽  
Molecular Genetic ◽  
Uterine Cavity ◽  
Reproductive Technologies ◽  
Genetic Characteristics ◽  
Vitro Fertilization ◽  
Need To Evaluate ◽  
The Relationship

The aim of the study is to systematically analyze the data available in the modern literature on the relationship between endometrial thickness and the frequency of pregnancy in the program of assisted reproductive technologies (ART). Materials and methods. The review includes data from foreign and domestic articles found in PubMed on this topic. Results. The article presents data on the relationship between the thickness of the endometrium and the frequency of pregnancy in ART programs. The greatest number of studies is devoted to the evaluation of the relationship between the thickness of the endometrium and the frequency of pregnancy on the day of the ovulation trigger. Data are presented on the existence of a correlation between the thickness of the endometrium measured on the day of the ovulation trigger and the frequency of clinical pregnancy, as well as data on the need to evaluate the structure of the endometrium and the state of subendometric blood flow. The importance of multilayered (three-layered) endometrium as a prognostic marker of success in in vitro fertilization/intracytoplasmic sperm injection programs in the ovum is emphasized. The conclusion. The thickness of the endometrium can not be used as an argument for canceling the cycle or abolishing embryo transfer to the uterine cavity. Further studies in this direction are needed with a study of the morphological and molecular genetic characteristics of the endometrium, which in the future will allow us to evaluate the relationship between the thickness of the endometrium and the probability of pregnancy.

Sign in / Sign up

Export Citation Format

Share Document